STUDIES ON THE HUMAN ADDICTION LIABILITY OF 2'-HYDROXY-5-9-DIMETHYL-2-(3,3-DIMETHYLALLYL)-6,7-BENZOMORPHAN (WIN 20,228): A WEAK NARCOTIC ANTAGONIST.
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D016739:Behavior, Addictive; D001575:Benzomorphans; D035843:Biomedical Research; D011431:Dextropropoxyphene; D006571:Heterocyclic Compounds; D006801:Humans; D009020:Morphine; D009021:Morphine Dependence; D009292:Narcotic Antagonists; D009294:Narcotics; D010423:Pentazocine; D019966:Substance-Related Disorders
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D001575:Benzomorphans; D006571:Heterocyclic Compounds; D009292:Narcotic Antagonists; D009294:Narcotics; D009020:Morphine; D010423:Pentazocine; D011431:Dextropropoxyphene
ANALGESICS AND ANTIPYRETICS; CLINICAL RESEARCH; DRUG ADDICTION; HETEROCYCLIC COMPOUNDS; MORPHINE; MORPHINE ADDICTION; NARCOTIC ANTAGONISTS; PENTAZOCINE; PROPOXYPHENE